| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |